Tuberculosis spondylodiscitis in a patient with psoriatic arthritis on targeted synthetic disease-modifying antirheumatic drugs – case report

Tuberkulozni spondilodisciTis, Adelmo Šegota, T. Schnurrer-Luke-Vrbanić, danijela Veljković-Vujaklija, V. Avancini-Dobrović, Doris Stamenković
{"title":"Tuberculosis spondylodiscitis in a patient with psoriatic arthritis on targeted synthetic disease-modifying antirheumatic drugs – case report","authors":"Tuberkulozni spondilodisciTis, Adelmo Šegota, T. Schnurrer-Luke-Vrbanić, danijela Veljković-Vujaklija, V. Avancini-Dobrović, Doris Stamenković","doi":"10.33004/reumatizam-68-2-4","DOIUrl":null,"url":null,"abstract":"Tuberculosis (Tb) has been recognised as an important opportunistic infection that occurs in patients with inflammatory rheumatic diseases. The results of global registries show that the risk of reactivation of latent Tb or the development of new Tb infection increases in patients treated with tumour necrosis factor inhibitors (Tnfis). However","PeriodicalId":76426,"journal":{"name":"Reumatizam","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reumatizam","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33004/reumatizam-68-2-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Tuberculosis (Tb) has been recognised as an important opportunistic infection that occurs in patients with inflammatory rheumatic diseases. The results of global registries show that the risk of reactivation of latent Tb or the development of new Tb infection increases in patients treated with tumour necrosis factor inhibitors (Tnfis). However
银屑病关节炎结核性脊柱炎1例靶向合成抗风湿药物治疗
结核病(Tb)已被认为是一种重要的机会感染,发生在炎性风湿性疾病患者中。全球登记的结果表明,在接受肿瘤坏死因子抑制剂(Tnfis)治疗的患者中,潜在Tb重新激活或发展为新Tb感染的风险增加。然而
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信